# High-intensity interval training and beta-hydroxy-beta-methylbutyric free acid improves aerobic power and metabolic thresholds

PMID: 24782684
Journal: Journal of the International Society of Sports Nutrition
Published: 2014
Authors: Robinson EH 4th, Stout JR, Miramonti AA, Fukuda DH, Wang R, Townsend JR, Mangine GT, Fragala MS, Hoffman JR

## Question

Does HMB free acid supplementation enhance aerobic fitness and metabolic-threshold adaptations to four weeks of cycle-ergometer HIIT in healthy college-aged men and women?

## Summary

In healthy college-aged adults, four weeks of cycling HIIT improved some endurance measures, and adding HMB free acid produced larger gains in VO2peak and ventilatory threshold than HIIT with placebo. Body composition did not significantly change, and the study is partly supplement evidence rather than workout-only evidence.

## Population

- Healthy recreationally active college-aged men and women
- Sample size: 34
- Age: 22.7 +/- 3.1 years
- Sex: 19 men, 15 women
- Fitness level: Recreationally active with minimum VO2peak thresholds
- Health status: Self-reported free of musculoskeletal injury

## Methodology

- Double-blind placebo-controlled training study with non-training control
- 4 weeks
- Human performance laboratory cycle ergometer training
- Randomized and controlled study design.

## Protocol

- HMBFA-HIIT.
- Modality: Cycle ergometer.
- Work intervals: 2 minutes.
- Recovery: 1 minute complete rest.
- Sets or repetitions: 5-6 bouts.
- Intensity: 80-120% maximal workload.
- Session duration: About 19-23 minutes including warm-up.
- Frequency: 3 sessions/week.
- Program length: 4 weeks.
- Progression: Alternating submaximal/supramaximal workload sessions.
- Placebo-HIIT / control.
- Modality: Cycle ergometer for placebo-HIIT; normal activity for control.
- Work intervals: 2 minutes for placebo-HIIT.
- Recovery: 1 minute complete rest for placebo-HIIT.
- Sets or repetitions: 5-6 bouts for placebo-HIIT.
- Intensity: 80-120% maximal workload for placebo-HIIT.
- Session duration: About 19-23 minutes including warm-up.
- Frequency: 3 sessions/week for placebo-HIIT.
- Program length: 4 weeks.
- Progression: Same as intervention for placebo-HIIT.

## Outcomes

### VO2peak
Status: improved
HMBFA-HIIT had greater VO2peak gains than control and placebo-HIIT.

ANCOVA p=0.003 overall; HMBFA-HIIT vs CTL p=0.001, vs PLA-HIIT p=0.032

### thresholds
Status: improved
HMBFA-HIIT improved ventilatory threshold; both HIIT groups improved RCP compared with control.

Reported p<0.05

### time to exhaustion
Status: improved
Both HIIT groups improved time to exhaustion versus control without significant difference between HIIT groups.

Reported p<0.05 versus CTL

### body composition
Status: no clear change
No significant differences were observed for body composition.

## Practical Insights

- Two-minute cycling intervals with short rest can build aerobic threshold and performance.
- Use supplement-linked claims only as background, not core HIIT generation evidence.
- No body-composition change after 4 weeks despite performance gains.

## Limitations

- Small groups
- Supplement co-intervention
- Short 4-week duration
- No detailed adverse-event reporting
- Healthy college sample

## Safety And Adherence

- The article did not report intervention-related adverse events, injuries, or symptoms.
- Before final analysis, 3 female and 2 male participants were removed for health reasons not associated with the study, and 1 female participant was removed after a family emergency.
- Participants self-reported no musculoskeletal injury on PAR-Q, gave informed consent after risks and benefits were explained, and supplement logs/returned packets showed 99% compliance.

## Original Sources

- [PubMed](https://pubmed.ncbi.nlm.nih.gov/24782684/) (pubmed)
- [DOI](https://doi.org/10.1186/1550-2783-11-16) (doi)
- [PMC full text](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004506/) (full text)

## Agent Guidance

Preserve the paper-level scope of this note. Do not generalize beyond the population, protocol, measured outcomes, and limitations above.